Analysts’ Viewpoint
Rise in cases of kidney stones, urinary tract infections, and other urinary complications are propelling the demand for ureteral stents and fueling the ureteral stents market size.
Technological advancements in stent design and materials are enhancing their efficacy and patient comfort, further driving market progress.
Innovations such as drug-eluting stents, biodegradable stents, and minimally invasive insertion techniques are reshaping the landscape of ureteral stent usage, offering better outcomes and reducing patient discomfort.
The high cost associated with advanced stent technologies, and reimbursement issues in certain regions is hampering the market. Additionally, complications and precautions with urinary stent placement such as stent migration, encrustation, and infection remain significant challenges for clinicians and patients alike.
Nevertheless, government support for healthcare infrastructure development and initiatives to improve access to urological care are likely to offer lucrative opportunities for market expansion.
Ureteral stents are medical devices used in urology to address various conditions affecting the urinary tract, particularly the ureters. These thin, flexible tubes are inserted into the ureter to ensure proper urine flow from the kidneys to the bladder, bypassing obstructions and facilitating healing after surgical procedures.
The ureteral stents market encompasses a range of products designed to meet the diverse needs of patients, offering different materials, sizes, and designs to suit individual anatomical variations and medical requirements.
The primary purpose of a ureteral stent is to maintain or restore the flow of urine from the kidney to the bladder. They are commonly used to manage conditions such as kidney stones, tumors, ureteral strictures, or other obstructions that impede the natural flow of urine through the ureter.
Furthermore, they are utilized postoperatively to prevent complications such as swelling or scarring that could obstruct the ureter.Ureteral stents typically consist of a hollow tube made from biocompatible materials such as silicone or polyurethane.
These materials are chosen for their flexibility, durability, and compatibility with bodily tissues. The stent is designed to be inserted into the ureter via cystoscopy, a minimally invasive procedure in which a thin, flexible instrument with a camera is passed through the urethra and into the bladder.
Continued innovation in stent design, materials, and manufacturing processes, coupled with efforts to address clinical concerns and improve patient outcomes, are crucial for sustaining growth and meeting the evolving needs of patients with urinary tract disorders.
Lifestyle factors, including sedentary habits and dietary patterns, are leading to increased incidence of kidney-related ailments. The rise in aging populations further compounds this issue, as age is a significant risk factor for urological conditions.
The American Urological Association (AUA) estimates that prostate cancer is the most common cancer diagnosed in men in the United States, and that bladder cancer is the fourth most common cancer diagnosed in women.
The role of urinary tract stents in urological procedures is crucial, offering a minimally invasive solution. As the incidence of kidney stones and other urological issues continues to increase, the demand for ureteral stabilizers or ureteral stents has experienced a parallel ascent.
These flexible tubes, inserted into the ureter, provide structural support and facilitate the unobstructed flow of urine, relieving patients from the debilitating symptoms associated with urological disorders. These factors are expected to bolster the ureteral stents industry growth.
One of the primary factors contributing to the importance of early diagnosis is the potential severity of untreated ureteral conditions. Ureteral obstructions, strictures, or kidney stones can lead to complications such as kidney damage, infection, or even complete renal failure if left untreated.
Therefore, detecting these conditions early through regular check-ups, symptom awareness, and diagnostic tests becomes crucial to prevent further complications and preserve renal function.
Furthermore, early diagnosis allows for timely intervention, which often involves the placement of urological support tubes such as ureteral stents. These stents serve multiple purposes, including relieving obstruction, facilitating urine flow, and preventing complications such as kidney damage and infection.
By maintaining proper drainage and supporting kidney function, ureteral stents contribute significantly to the overall management and treatment outcomes of various urological conditions, thus bolstering the ureteral stents market revenue.
Physicians, urologists, and other healthcare providers are increasingly emphasizing the significance of timely diagnosis and intervention in managing ureteral disorders.
This emphasis is reflected in clinical guidelines, educational initiatives, and public health campaigns aimed at raising awareness about urological health and encouraging proactive healthcare-seeking behavior.
As per the urinary stents market analysis, the double pigtail stents dominates based on product type. Their design allows for effective drainage of urine from the kidneys to the bladder while minimizing the risk of stent migration or dislodgement.
The design feature enhances patient comfort and reduces the need for frequent repositioning or replacement, leading to higher patient satisfaction rates.
Furthermore, double pigtail stents offer excellent biocompatibility, reducing the likelihood of adverse reactions or complications such as infection or tissue irritation.
Their flexible structure also enables easier insertion and removal, making them highly preferred by healthcare professionals for various urological interventions.
The urinary stents market insights highlights the fact that North America has a formidable position in the industry. North America benefits from advanced healthcare infrastructure and technology, facilitating widespread adoption of medical devices including ureteral stents.
The region's well-established healthcare systems ensure timely diagnosis and treatment, fostering a conducive environment for urological procedures that necessitate ureteral stent placement.
North America accounts for high prevalence of urological disorders, including kidney stones, urinary tract infections, and urinary obstructions, driving the demand for ureteral stents. The region's aging population and changing lifestyles leading to an increase in risk factors such as obesity and sedentary behavior, further contributes to the growing incidence of urological conditions.
Consequently, healthcare providers in the region routinely utilize ureteral stents for various therapeutic and diagnostic purposes.
Asia Pacific is expected to generate considerable ureteral stents market demand, and is poised to exhibit the highest compound annual growth rate (CAGR) during the forecast period. Rapid urbanization and industrialization in countries such as China and India have resulted in lifestyle changes, leading to increased incidence of urological disorders.
Additionally, improving healthcare infrastructure and surge in healthcare expenditure in the region facilitates better access to urological care, including the placement of ureteral stents.
According to the ureteral stents market report, key players are engaging in mergers & acquisitions, strategic collaborations, and new product launches to expand their presence and gain significant ureteral stents industry share.
Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Americas, Coloplast Corporation, Merit Medical Systems, Inc., and Becton, Dickinson, and Company are the prominent ureteral stents market manufacturers.
The ureteral stents market research report profiles the top players based on various factors including a company overview, financial summary, strategies, product portfolio, segments, and recent advancements.
Attribute | Detail |
---|---|
Size in 2022 | US$ 488.2 Mn |
Forecast (Value) in 2031 | More than US$ 823.7 Mn |
Growth Rate (CAGR) 2023-2031 | 5.9% |
Forecast Period | 2023-2031 |
Historical Data Available for | 2017-2021 |
Quantitative Units | US$ Mn for Value |
Market Analysis | It includes segment analysis as well as regional-level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available upon request |
Pricing | Available upon request |
It was valued at US$ 488.2 Mn in 2022
It is projected to reach more than US$ 823.7 Mn by the end of 2031
The CAGR is anticipated to be 5.9% from 2023 to 2031
By product type, the double pigtail stents segment accounted for largest share in 2022
North America is anticipated to account for leading share during the forecast period.
Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Americas, Coloplast Corporation, Merit Medical Systems, Inc., and Becton, Dickinson, and Company
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Ureteral Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Ureteral Stents Market Analysis and Forecasts, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Overview of Applications of Ureteral Stents
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Regulatory Scenario by Region/globally
5.4. Technological Advancements and Innovation in Stent Material
5.5. COVID-19 Pandemic Impact on Industry
6. Global Ureteral Stents Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2017-2031
6.3.1. Open End Stents
6.3.2. Closed End Stents
6.3.3. Double Pigtail Stents
6.3.4. Multiloop Stents
6.4. Market Attractiveness By Product Type
7. Global Ureteral Stents Market Analysis and Forecasts, By Material
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Material, 2017-2031
7.3.1. Metallic Stents
7.3.2. Polymer Stents
7.3.2.1. Silicone Stents
7.3.2.2. Polyurethane Stents
7.3.2.3. Hybrid Stents
7.3.3. Biodegradable Hydrogel Stents
7.4. Market Attractiveness By Material
8. Global Ureteral Stents Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2017-2031
8.3.1. Kidney Stones
8.3.2. Kidney Failure
8.3.3. Urinary Tract Infection
8.3.4. Urinary Incontinence
8.3.5. Others (Tumor, Kidney injuries, etc.)
8.4. Market Attractiveness By Application
9. Global Ureteral Stents Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2017-2031
9.3.1. Hospitals & Specialty Centers
9.3.2. Ambulatory Surgical Centers
9.3.3. Academic and Research Institutes
9.4. Market Attractiveness By End-user
10. Global Ureteral Stents Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Ureteral Stents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2017-2031
11.2.1. Open End Stents
11.2.2. Closed End Stents
11.2.3. Double Pigtail Stents
11.2.4. Multiloop Stents
11.3. Market Value Forecast By Material, 2017-2031
11.3.1. Metallic Stents
11.3.2. Polymer Stents
11.3.2.1. Silicone Stents
11.3.2.2. Polyurethane Stents
11.3.2.3. Hybrid Stents
11.3.3. Biodegradable Hydrogel Stents
11.4. Market Value Forecast By Application, 2017-2031
11.4.1. Kidney Stones
11.4.2. Kidney Failure
11.4.3. Urinary Tract Infection
11.4.4. Urinary Incontinence
11.4.5. Others (Tumor, Kidney injuries, etc.)
11.5. Market Value Forecast By End-user, 2017-2031
11.5.1. Hospitals & Specialty Centers
11.5.2. Ambulatory Surgical Centers
11.5.3. Academic and Research Institutes
11.6. Market Value Forecast By Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Material
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Ureteral Stents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2017-2031
12.2.1. Open End Stents
12.2.2. Closed End Stents
12.2.3. Double Pigtail Stents
12.2.4. Multiloop Stents
12.3. Market Value Forecast By Material, 2017-2031
12.3.1. Metallic Stents
12.3.2. Polymer Stents
12.3.2.1. Silicone Stents
12.3.2.2. Polyurethane Stents
12.3.2.3. Hybrid Stents
12.3.3. Biodegradable Hydrogel Stents
12.4. Market Value Forecast By Application, 2017-2031
12.4.1. Kidney Stones
12.4.2. Kidney Failure
12.4.3. Urinary Tract Infection
12.4.4. Urinary Incontinence
12.4.5. Others (Tumor, Kidney injuries, etc.)
12.5. Market Value Forecast By End-user, 2017-2031
12.5.1. Hospitals & Specialty Centers
12.5.2. Ambulatory Surgical Centers
12.5.3. Academic and Research Institutes
12.6. Market Value Forecast By Country, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Material
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Ureteral Stents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2017-2031
13.2.1. Open End Stents
13.2.2. Closed End Stents
13.2.3. Double Pigtail Stents
13.2.4. Multiloop Stents
13.3. Market Value Forecast By Material, 2017-2031
13.3.1. Metallic Stents
13.3.2. Polymer Stents
13.3.2.1. Silicone Stents
13.3.2.2. Polyurethane Stents
13.3.2.3. Hybrid Stents
13.3.3. Biodegradable Hydrogel Stents
13.4. Market Value Forecast By Application, 2017-2031
13.4.1. Kidney Stones
13.4.2. Kidney Failure
13.4.3. Urinary Tract Infection
13.4.4. Urinary Incontinence
13.4.5. Others (Tumor, Kidney injuries, etc.)
13.5. Market Value Forecast By End-user, 2017-2031
13.5.1. Hospitals & Specialty Centers
13.5.2. Ambulatory Surgical Centers
13.5.3. Academic and Research Institutes
13.6. Market Value Forecast By Country, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Material
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country
14. Latin America Ureteral Stents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2017-2031
14.2.1. Open End Stents
14.2.2. Closed End Stents
14.2.3. Double Pigtail Stents
14.2.4. Multiloop Stents
14.3. Market Value Forecast By Material, 2017-2031
14.3.1. Metallic Stents
14.3.2. Polymer Stents
14.3.2.1. Silicone Stents
14.3.2.2. Polyurethane Stents
14.3.2.3. Hybrid Stents
14.3.3. Biodegradable Hydrogel Stents
14.4. Market Value Forecast By Application, 2017-2031
14.4.1. Kidney Stones
14.4.2. Kidney Failure
14.4.3. Urinary Tract Infection
14.4.4. Urinary Incontinence
14.4.5. Others (Tumor, Kidney injuries, etc.)
14.5. Market Value Forecast By End-user, 2017-2031
14.5.1. Hospitals & Specialty Centers
14.5.2. Ambulatory Surgical Centers
14.5.3. Academic and Research Institutes
14.6. Market Value Forecast By Country, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Material
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Ureteral Stents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2017-2031
15.2.1. Open End Stents
15.2.2. Closed End Stents
15.2.3. Double Pigtail Stents
15.2.4. Multiloop Stents
15.3. Market Value Forecast By Material, 2017-2031
15.3.1. Metallic Stents
15.3.2. Polymer Stents
15.3.2.1. Silicone Stents
15.3.2.2. Polyurethane Stents
15.3.2.3. Hybrid Stents
15.3.3. Biodegradable Hydrogel Stents
15.4. Market Value Forecast By Application, 2017-2031
15.4.1. Kidney Stones
15.4.2. Kidney Failure
15.4.3. Urinary Tract Infection
15.4.4. Urinary Incontinence
15.4.5. Others (Tumor, Kidney injuries, etc.)
15.5. Market Value Forecast By End-user, 2017-2031
15.5.1. Hospitals & Specialty Centers
15.5.2. Ambulatory Surgical Centers
15.5.3. Academic and Research Institutes
15.6. Market Value Forecast By Country, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Material
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2022)
16.3. Company Profiles
16.3.1. Boston Scientific Corporation
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. B. Braun Melsungen AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Teleflex Incorporated
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Olympus Americas
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Coloplast Corporation
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Merit Medical Systems, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Becton, Dickinson, and Company
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
List of Tables
Table 01: Global Ureteral Stents Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Ureteral Stents Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 03: Global Ureteral Stents Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Ureteral Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Ureteral Stents Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Ureteral Stents Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America Ureteral Stents Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 08: North America Ureteral Stents Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 09: North America Ureteral Stents Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 10: North America Ureteral Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Ureteral Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Ureteral Stents Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 13: Europe Ureteral Stents Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 14: Europe Ureteral Stents Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 15: Europe Ureteral Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Ureteral Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Ureteral Stents Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 18: Asia Pacific Ureteral Stents Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 19: Asia Pacific Ureteral Stents Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Asia Pacific Ureteral Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Ureteral Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Ureteral Stents Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 23: Latin America Ureteral Stents Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 24: Latin America Ureteral Stents Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 25: Latin America Ureteral Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 28: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Forecast, by Material, 2017-2031
Table 29: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 30: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Ureteral Stents Market Size, by Product Type, 2022
Figure 02: Global Ureteral Stents Market Share (%), by Product Type, 2022
Figure 03: Global Ureteral Stents Market Size, by Material, 2022
Figure 04: Global Ureteral Stents Market Share (%), by Material, 2022
Figure 05: Global Ureteral Stents Market Size, by Application, 2022
Figure 06: Global Ureteral Stents Market Share (%), by Application, 2022
Figure 07: Global Ureteral Stents Market Size, by End-user, 2022
Figure 08: Global Ureteral Stents Market Share (%), by End-user, 2022
Figure 09: Global Ureteral Stents Market, by Region (2022-2031)
Figure 10: Global Ureteral Stents Market Value (US$ Mn) Forecast, 2017-2031
Figure 11: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Product Type, 2022-2031
Figure 12: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Product Type, 2022
Figure 13: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Product Type, 2031
Figure 14: Global Ureteral Stents Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 15: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Material, 2022-2031
Figure 16: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Material, 2022
Figure 17: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Material, 2031
Figure 18: Global Ureteral Stents Market Attractiveness Analysis, by Material, 2023-2031
Figure 19: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
Figure 20: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Application, 2022
Figure 21: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Application, 2031
Figure 22: Global Ureteral Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 23: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
Figure 24: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by End-user, 2022
Figure 25: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by End-user, 2031
Figure 26: Global Ureteral Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 27: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Region, 2022-2031
Figure 28: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Region, 2022
Figure 29: Global Ureteral Stents Market Value (US$ Mn) Share Analysis, by Region, 2031
Figure 30: Global Ureteral Stents Market Attractiveness Analysis, by Region, 2023-2031
Figure 31: North America Ureteral Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 32: North America Ureteral Stents Market Value Share Analysis, by Country, 2022-2031
Figure 33: North America Ureteral Stents Market Attractiveness Analysis, by Country, 2023-2031
Figure 34: North America Ureteral Stents Market Value (US$ Mn) Share Analysis, by Product Type, 2022-2031
Figure 35: North America Ureteral Stents Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 36: North America Ureteral Stents Market Value (US$ Mn) Share Analysis, by Material, 2022-2031
Figure 37: North America Ureteral Stents Market Attractiveness Analysis, by Material, 2023-2031
Figure 38: North America Ureteral Stents Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
Figure 39: North America Ureteral Stents Market Attractiveness Analysis, by Application, 2023-31
Figure 40: North America Ureteral Stents Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
Figure 41: North America Ureteral Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 42: Europe Ureteral Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 43: Europe Ureteral Stents Market Value Share Analysis, by Country/Sub-region, 2022-2031
Figure 44: Europe Ureteral Stents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 45: Europe Ureteral Stents Market Value (US$ Mn) Share Analysis, by Product Type, 2022-2031
Figure 46: Europe Ureteral Stents Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 47: Europe Ureteral Stents Market Value (US$ Mn) Share Analysis, by Material, 2022-2031
Figure 48: Europe Ureteral Stents Market Attractiveness Analysis, by Material, 2023-2031
Figure 49: Europe Ureteral Stents Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
Figure 50: Europe Ureteral Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 51: Europe Ureteral Stents Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
Figure 52: Europe Ureteral Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 53: Asia Pacific Ureteral Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 54: Asia Pacific Ureteral Stents Market Value Share Analysis, by Country/Sub-region, 2022-2031
Figure 55: Asia Pacific Ureteral Stents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 56: Asia Pacific Ureteral Stents Market Value (US$ Mn) Share Analysis, by Product Type, 2022-2031
Figure 57: Asia Pacific Ureteral Stents Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 58: Asia Pacific Ureteral Stents Market Value (US$ Mn) Share Analysis, by Material, 2022-2031
Figure 59: Asia Pacific Ureteral Stents Market Attractiveness Analysis, by Material, 2023-2031
Figure 60: Asia Pacific Ureteral Stents Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
Figure 61: Asia Pacific Ureteral Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 62: Asia Pacific Ureteral Stents Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
Figure 63: Asia Pacific Ureteral Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 64: Latin America Ureteral Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 65: Latin America Ureteral Stents Market Value Share Analysis, by Country/Sub-region, 2022-2031
Figure 66: Latin America Ureteral Stents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 67: Latin America Ureteral Stents Market Value (US$ Mn) Share Analysis, by Product Type, 2022-2031
Figure 68: Latin America Ureteral Stents Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 69: Latin America Ureteral Stents Market Value (US$ Mn) Share Analysis, by Material, 2022-2031
Figure 70: Latin America Ureteral Stents Market Attractiveness Analysis, by Material, 2023-2031
Figure 71: Latin America Ureteral Stents Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
Figure 72: Latin America Ureteral Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 73: Latin America Ureteral Stents Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
Figure 74: Latin America Ureteral Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 75: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 76: Middle East & Africa Ureteral Stents Market Value Share Analysis, by Country/Sub-region, 2022-2031
Figure 77: Middle East & Africa Ureteral Stents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 78: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Share Analysis, by Product Type, 2022-2031
Figure 79: Middle East & Africa Ureteral Stents Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 80: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Share Analysis, by Material, 2022-2031
Figure 81: Middle East & Africa Ureteral Stents Market Attractiveness Analysis, by Material, 2023-2031
Figure 82: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Share Analysis, by Application, 2022-2031
Figure 83: Middle East & Africa Ureteral Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 84: Middle East & Africa Ureteral Stents Market Value (US$ Mn) Share Analysis, by End-user, 2022-2031
Figure 85: Middle East & Africa Ureteral Stents Market Attractiveness Analysis, by End-user, 2023-2031